Global Digital Therapeutics Market to Potentially Generate Higher Valuation By 2Posted by Apeksha on July 16th, 2021 Digital Therapeutics Market Research Analysis By Product Type (Software, Devices And Others), Application (Cardiovascular Diseases, Obesity, Diabetes, Respiratory Diseases, Smoking Cessation and Others) and Sales Channel (B2B and B2C) and End Users - Global Forecast 2027 Market Highlight Digital therapeutics play a fundamental role in incorporating digital elements into traditional medical devices. The global digital therapeutics market depends on this factor significantly, and based on this, it could expect an impactful growth with substantial CAGR during the forecast period (2018-2023), reveals Market Research Future (MRFR) in an extensively studied report. The study further states that the market can even double its valuation by 2023 than the past. Market Drivers & Challenges The ability of digital therapeutics, such as encompassing a multitude of current medical devices and technologies, offers proper traction has made it vulnerable that makes the market gross largely. Even the market is said to be ever-growing and expanding at a rapid pace due to the introduction of current medical devices and technologies. Regional Outlook Region-wise, the digital therapeutics market is analyzed across central regions of Asia-Pacific, Europe, North America, and LAMEA. Market Key Players The global digital therapeutics market is manifested by the incidence of big players such as Proteus Digital Health, Inc., Twine Health Inc., Propeller Health, Omada Health, Inc., Mango Health, Inc., Medtronic Plc., Noom Inc, WellDoc Inc., Canary Health Inc., and Livongo Health. Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/digital-therapeutics-market-6492 Contact: Akash Anand Market Research Future +1 646 845 9312 Like it? Share it! More by this author |